"The pandemic of COVID-19 is a challenge for all and needs a concerted effort to overcome", said Dr Habil Khorakiwala, the Founder Chairman of Wockhardt.
The scientists of Harvard's Beth Israel Deaconess Medical Center and J&J studies seven various vaccines in 32 animals in the monkey study and compares the results with 20 control animals to whom placebo shots have been given.
Fauci also cautioned that although data suggests that young children do not get seriously ill from COVID-19, they are still capable of getting infected and spreading the virus. And in a bid to market a working vaccine by the end of this year, governments across the world are setting up incentive structures that could entice manufacturers to go all in. "Clinical trials for phase I, II of both the vaccine candidates have started".
"If this happens in the next ten days, we will be ahead not just of the United States but other countries too, it will be the first registered coronavirus vaccine", RDIF chief Kirill Dmitriev said in televised remarks.
The deal was made under the administration's Operation Warp Speed, which aims to accelerate the development process of COVID-19 vaccines.
CDC's vaccine advisers wanted to know who's really essential.
If an agreement is reached with the EU, the doses of Sanofi/GSK's candidate will be manufactured in European countries including France, Belgium, Germany and Italy. But these aren't ordinary circumstances and we aren't developing a regular vaccine.
Sanofi and GSK's drug is a so-called recombinant protein-based vaccine, which means that it involves using DNA to encode an antigen, toxin or other foreign substance, which induces an immune response in the vaccinated person. Currently, pregnant women are recommended to take flu and whooping cough vaccines and certain others depending on individual circumstances, but none of these have been specifically tested and proven safe for pregnant women.
"Even if you have an optimistic assessment of the scientific progress, there's still not enough vaccines for the world", according to Airfinity's CEO Rasmus Bech Hansen.
More than 100 possible vaccines are being developed around the world to try and tackle the COVID-19 pandemic.
For all the promises of the USA stockpiling millions of doses, the hard truth: Even if a vaccine is declared safe and effective by year's end, there won't be enough for everyone who wants it right away - especially as most potential vaccines require two doses. Last month, they launched their latest initiative - the COVAX Facility.